Overall demand for NRT smoking cessation aids in Australia remains above pre-pandemic levels, in line with an ongoing fall in smoking prevalence among adult smokers. According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and 2022-2023.
The NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN AUSTRALIADISCLAIMERDEFINITIONS
2024 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY INDICATORS
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
